X
Lung cancer drug Keytruda to become routinely available on NHS
https://pharmaphorum.com/news/lung-cancer-drug-keytruda-nhs/
MSD
Despite ‘no pick and mix’ warning, pharma’s Brexit planners still hope for deal
The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.
MSD attracts top British scientist to head up UK discovery centre
Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.
NHS must drive forward life sciences strategy, says Lords’ leader
Big pharma investment “very important”, says peer.
Sanofi Pasteur and MSD end vaccines joint venture
Companies end collaboration after more than 20 years.
Keytruda set for first line lung cancer use in EU
MSD drug will not face competition from BMS rival in this use.
NICE approval for Keytruda a ‘milestone’ in lung cancer
But drug will not be funded for longer than two years.
1 2
